Internal Medicine, Cardiovascular Disease · Santa Monica, CA
NPI
1225353592
Since 2010
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
2001 Santa Monica Blvd Ste 280w
Santa Monica, CA, 90404
Phone (310) 829-7678
Groups this clinician bills Medicare through
Medicare paid, 2024
$356K
12,609 services
Medicare patients, 2024
1,181
Average age 77
Drug cost, 2024
$892K
3,994 prescriptions
Company payments, 2025
$795
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jordan C Kawano was code J1306 (injection, inclisiran, 1 mg), 8,804 times for 19 patients. In total Jordan C Kawano billed 12,609 services in 40 codes, and Medicare paid $356K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1306 Injection, inclisiran, 1 mg | Office | 8,804 | 19 | $9.51 | $84K |
| 99214 Office E&M - Established | Office | 846 | 392 | $99.63 | $84K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 662 | 357 | $12.89 | $8,532 |
| 93306 Echocardiography (TTE/TEE) | Office | 511 | 492 | $168.65 | $86K |
| 93356 Echocardiography (TTE/TEE) | Office | 397 | 384 | $33.20 | $13K |
| 93000 Electrocardiogram | Office | 273 | 220 | $11.54 | $3,151 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 268 | 267 | $167.28 | $45K |
| 93244 Electrocardiogram | Office | 125 | 119 | $18.11 | $2,264 |
| 93242 Electrocardiogram | Office | 118 | 112 | $10.48 | $1,237 |
| 93248 Electrocardiogram | Office | 112 | 106 | $19.90 | $2,229 |
| 93246 Electrocardiogram | Office | 106 | 101 | $10.41 | $1,103 |
| 93306 Echocardiography (TTE/TEE) | Facility | 86 | 85 | $53.26 | $4,580 |
| 99204 Office E&M - New | Office | 50 | 50 | $114.98 | $5,749 |
| 96372 Injection Administration | Office | 31 | 19 | $12.63 | $392 |
| 87635 COVID Specific | Office | 29 | 28 | $50.28 | $1,458 |
By year: 2022 $250K for 3,670 services; 2023 $245K for 5,443 services; 2024 $356K for 12,609 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87635 COVID Specific | 29 | 28 | $50.28 | $1,458 |
| 36415 Venipuncture Blood Collection | 22 | 20 | $8.65 | $190 |
Medicare prescription drug claims, 2024
In 2024, the drug Jordan C Kawano prescribed most often to Medicare patients was Rosuvastatin Calcium, with 481 prescriptions and refills. In total Jordan C Kawano wrote 3,994 Medicare prescriptions that cost $892K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 481 | 1,267 | 146 | $8,119 |
| Atorvastatin Calcium Generic | 467 | 1,297 | 144 | $5,899 |
| Amlodipine Besylate Generic | 323 | 867 | 94 | $1,980 |
| Metoprolol Succinate Generic | 257 | 703 | 69 | $4,740 |
| Eliquis Apixaban | 188 | 350 | 46 | $202K |
| Repatha Sureclick Evolocumab | 183 | 330 | 48 | $187K |
| Losartan Potassium Generic | 170 | 485 | 52 | $2,042 |
| Ezetimibe Generic | 150 | 371 | 43 | $5,982 |
| Carvedilol Generic | 149 | 369 | 39 | $1,324 |
| Entresto Sacubitril/Valsartan | 129 | 202 | 26 | $134K |
| Valsartan Generic | 100 | 285 | 31 | $3,096 |
| Pravastatin Sodium Generic | 97 | 247 | 35 | $1,121 |
| Lisinopril Generic | 71 | 216 | 23 | $510 |
| Furosemide Generic | 70 | 184 | 23 | $451 |
| Repatha Syringe Evolocumab | 61 | 132 | 19 | $76K |
Brand drugs: 832 claims; generic drugs: 3,162 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jordan C Kawano $795 ($795 in general payments such as food, travel and fees) from 14 companies. The largest payer was Novartis Pharmaceuticals Corporation with $307.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 16 | $307 |
| Amgen Inc. AMGN | 5 | $114 |
| Pfizer Inc. PFE | 4 | $66.94 |
| Novo Nordisk Inc NVO | 2 | $55.58 |
| Esperion Therapeutics, Inc. ESPR | 2 | $51.91 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $38.44 |
| Inspire Medical Systems, Inc. INSP | 1 | $32.5 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29.49 |
| Merck Sharp & Dohme LLC MRK | 1 | $28.68 |
| Kestra Medical Technology Services, Inc. | 1 | $21.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.